RT Journal Article
T1 Sex Differences in Patients With Occult Cancer After Venous Thromboembolism.
A1 Jara-Palomares, Luis
A1 Otero, Remedios
A1 Jiménez, David
A1 Praena-Fernández, Juan Manuel
A1 Rivas, Agustina
A1 Font, Carme
A1 Wells, Philip S
A1 López-Reyes, Raquel
A1 González-Martínez, José
A1 Monreal, Manuel
K1 deep vein thrombosis
K1 neoplasm
K1 pulmonary embolism
K1 sex
K1 venous thromboembolism
AB In patients with venous thromboembolism (VTE), male sex has been associated with an increased risk of occult cancer. The influence of sex on clinical characteristics, treatment, cancer sites, and outcome has not been thoroughly investigated yet. We used the Registro Informatizado Enfermedad TromboEmbólica registry to compare the clinical characteristics, treatment strategies, cancer sites, and clinical outcomes in patients with VTE having occult cancer, according to sex. As of June 2014, 5864 patients were recruited, of whom 444 (7.6%; 95% confidence interval: 6.8-8.2) had occult cancer. Of these, 246 (55%) were men. Median time elapsed from VTE to occult cancer was 4 months (interquartile range: 2-8.4), with no sex differences. Women were older, weighed less, and were less likely to have chronic lung disease than men. The most common cancer sites were the lung (n = 63), prostate (n = 42), and colorectal (n = 29) in men and colorectal (n = 38), breast (n = 23), uterine (n = 18), hematologic (n = 17), or pancreas (n = 15) in women. Men were more likely to have lung cancer than women (2.18% vs 0.30%; P 50 years.
YR 2017
FD 2017-07-06
LK http://hdl.handle.net/10668/11377
UL http://hdl.handle.net/10668/11377
LA en
DS RISalud
RD Apr 6, 2025